Ginkgo Bioworks Holdings, Inc. (DNA)
Ginkgo Bioworks Holdings, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Ginkgo Bioworks Holdings, Inc. (DNA) is a Biotechnology company based in US with a market capitalization of $515.4M. Revenue declined 25.1% year-over-year and free cash flow was negative at -$178.7M. This page tracks DNA's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 834 employees · IPO Apr 19, 2021
Valuation
Valuation & price
$7.71as of May 17, 2026· -52.2% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
1.01
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$515.4M
Market cap
-25.1%
Revenue growth (YoY)
81.5%
Gross margin
-$178.7M
Free cash flow (USD)
-$5.5M
Net debt
Net cash position
6.9%
Share dilution
1/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2019 → 2025
Free cash flow by year
2019 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
2
Insider sells · 90 days
Earnings
Last report: 10-Q filed May 7, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- Insider sellJul 20, 2026Filing
Insider Sell $6KCoen Steven P. · See remarks · $5.9K
- 8-K eventJun 12, 2026Filing
Annual Meeting Results
- Insider sellMay 26, 2026Filing
Insider Sell $3KCoen Steven P. · See remarks · $2.6K
- 8-K eventMay 7, 2026Filing
Earnings Release
- Quarterly reportMay 7, 2026Filing
10-Q Filed
- Insider sellApr 20, 2026Filing
Insider Sell $3KCoen Steven P. · See remarks · $2.6K
- Insider sellApr 14, 2026Filing
Insider Sell $213KCoen Steven P. · See remarks · $212.8K
- Insider sellApr 13, 2026Filing
Insider Sell $802KShetty Reshma P. · Director, See remarks, 10% Owner · $802.5K
- Insider sellApr 13, 2026Filing
Insider Sell $802KCanton Barry · 10% Owner · $802.5K
- Insider sellApr 10, 2026Filing
Insider Sell $1.4MKelly Jason R · Director, See remarks · $1.4M
Questions
Frequently asked questions
What is Ginkgo Bioworks Holdings, Inc.'s market cap?
Ginkgo Bioworks Holdings, Inc. (DNA) has a market capitalization of $515.4M.
What is DNA's P/E ratio?
A meaningful P/E ratio is not available for DNA — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is DNA's price-to-book (P/B) ratio?
DNA trades at 1.01 times book value per share.
Are insiders buying DNA stock?
SEC Form 4 filings show no open-market insider buys at Ginkgo Bioworks Holdings, Inc. in the last 90 days (2 sells).
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.